Product Image

K2 + D3 Calcium Gummies

4.7
★ ★ ★ ★ ★
(479 ratings)
Vitamin K 100 mcg
Product Image
Score79
A convenient D3, MK-7, and calcium gummy with well-chosen vitamin amounts. Calcium is modest, and the gummy adds carbohydrate without a lipid carrier.
How scoring works
Gummy
Quantity:60 Gummy(ies) • (60 servings)
Goals:
General Health
Anti-Aging
Bone Health
Cardiovascular Support
Heart Health

Score 79

A convenient D3, MK-7, and calcium gummy with well-chosen vitamin amounts. Calcium is modest, and the gummy adds carbohydrate without a lipid carrier.
How scoring works
$29.95($0.49 per serving)
iHerb
$ 29.95
Pure Formulas
$ 29.99
Vitacost
$ 29.95
Vitacost
$ 29.95
Report prices

Analysis

Vitamin D3 at 25 mcg and MK-7 at 100 mcg are well aligned for bone and calcium-handling support. Calcium at 100 mg adds a modest amount rather than replacing dietary calcium.

One gummy is convenient and all main active amounts are disclosed. Two grams of carbohydrate and no stated lipid carrier reduce formula efficiency.

The product suits users who value an easy gummy over maximum calcium depth. Taking it with a meal containing fat may better support absorption of vitamins D and K.

Who is it for
  • Adults seeking a bone-support gummy
  • Users who dislike capsules
  • People wanting D3 with MK-7
Best for
  • Vitamin D and K maintenance
  • Modest calcium support
  • Convenient gummy use

Pros

  • Target-range MK-7 amount
  • Useful 25 mcg D3 dose
  • Adds 100 mg calcium

Cons

  • Calcium contribution is modest
  • Two grams of carbohydrate
  • No stated lipid carrier

Warnings

  • The 100 mcg MK-7 amount can interfere with warfarin and other vitamin K antagonist anticoagulants; use requires clinician-guided consistency.

Nutrient quality

88 Highest impact

Meaningful vitamin D3 and MK-7 strongly fit bone and cardiovascular support. Modest calcium and a carbohydrate gummy base reduce formula efficiency.

.

Ingredient transparency

82 Highest impact

Most active ingredients and their amounts are clearly listed. Daily directions and a complete other-ingredients panel are not included in the supplied data.

.

Customer satisfaction

66 High impact

The aggregate rating is favorable and supported by moderate feedback volume. Complaint-level experiences are unavailable, so repeated drawbacks and purpose fit remain uncertain.

.

Value for money

77 High impact

The serving cost is reasonable for the documented actives. Form, dose, or delivery limits keep value from standing out further.

.
Report analysis

Goals

General Health
General Health
Impact
Highest effect
A+ Goal FitA Strength of SupportB CoverageA Formula Quality
Vitamin D · 25 mcgVitamin K · 100 mcg

Vitamin D3, vitamin K2, and calcium form a complementary combination for calcium handling and skeletal support. D3 and MK-7 are useful forms at well-targeted amounts, while the modest calcium dose adds support without dominating the formula.

The gummy is coherent but narrower than a full foundational nutrient formula, and it lacks a lipid carrier for the fat-soluble vitamins. The 100 mcg MK-7 amount can affect warfarin control, so people using vitamin K antagonist anticoagulants need clinician-guided consistency.

Study evidence
Vitamin K Supportive 34 studies
Anti-Aging
Anti-Aging
Impact
Highest effect
A- Goal FitA Strength of SupportB- CoverageA Formula Quality
Vitamin K · 100 mcgVitamin D · 25 mcg

MK-7 vitamin K2 at 100 mcg supports proteins that help keep calcium in bones and out of soft tissues. Vitamin D3 and calcium reinforce skeletal support, although the gummy has no stated lipid carrier.

The formula focuses on vascular and skeletal aging rather than mitochondrial, neurological, or glycation pathways. Vitamin K2 can oppose warfarin-type anticoagulants and requires prescriber guidance for users of those medicines.

Study evidence
Vitamin D Supportive 50 studies
Vitamin K Supportive 27 studies
Bone Health
Bone Health
Impact
Highest effect
A Goal FitB+ Strength of SupportB- CoverageA+ Formula Quality
Vitamin K · 100 mcgCalcium · 100 mgVitamin D · 25 mcg

Vitamin D3 and MK-7 vitamin K2 form a well-matched pair for calcium absorption and placement in bone. Calcium is also present, but its modest amount means the formula is better suited to targeted vitamin support than full mineral coverage.

The active forms and amounts are clearly identified, while the gummy does not include a lipid carrier for the fat-soluble vitamins. Vitamin K2 can alter warfarin control, so people using a vitamin K antagonist need clinician-guided consistency before changing intake.

Study evidence
Calcium Supportive 144 studies
Vitamin D Supportive 202 studies
Vitamin K Supportive 78 studies
Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
B- Goal FitA Strength of SupportC- CoverageA+ Formula Quality
Vitamin K · 100 mcgVitamin D · 25 mcg

Vitamin K2 as MK-7 and vitamin D3 form a targeted pair for calcium handling, while a modest calcium amount supplies substrate for that pathway. The mechanism is relevant to vascular health but does not cover lipids, blood pressure, rhythm, or cardiac energy.

All active forms and amounts are clear, and the K2 dose is meaningful. Vitamin K2 can interfere with warfarin and related vitamin K antagonist therapy, so use requires clinician-guided consistency.

Study evidence
Vitamin K Supportive 40 studies
Heart Health
Heart Health
Impact
High effect
B Goal FitB+ Strength of SupportC+ CoverageA- Formula Quality
Vitamin K · 100 mcgVitamin D · 25 mcg

Vitamin D3 and MK-7 form a relevant pair for calcium handling, while a small calcium amount supports the same pathway. The gummy is focused on mineral management rather than broad lipid or cardiac-energy support.

The K2 amount and MK-7 form are strong, though the gummy lacks a lipid carrier. Vitamin K2 can interfere with warfarin dosing and requires clinician-guided consistency during anticoagulation.

Study evidence
Vitamin D Mixed 164 studies
Vitamin K Mixed 62 studies

Ingredients

IngredientAmount per serving
Calories
10 Calorie(s)
Total Carbohydrates
2 Gram(s)
Vitamin D (Cholecalciferol)
 25 mcg
Calcium (Tribasic Calcium Phosphate)
 100 mg
Sodium
10 mg
Vitamin K2 (Menaquinone-7)
 100 mcg
Gluten Free Adults 18–50 Vegan Dairy Free Children 4+ Children 1–4 Vegetarian
Report overview
Vitamin K (Menaquinone-7) · 100 mcg OverallScore81
C Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyB+ Value

The 100 mcg MK-7 dose is clearly disclosed and fits the targeted range for bone and cardiovascular support. The moderate serving cost and added vitamin D3 support good value, although the gummy lacks a lipid carrier. The MK-7 dose can affect warfarin control, so people using vitamin K antagonist anticoagulants need clinician-guided consistency.

View ingredientView products
Loading alternative details
86 Performance

Liquid D-3 & MK-7

NOW
<p>Liquid delivery combines MK-7 with a substantial vitamin D3 amount and provides flexible dosing with strong bone- and heart-goal alignment. Vitamin D intake from other sources still matters, especially for the higher-dose options. Vitamin K requires clinician-directed consistency with warfarin-type medicines.</p>
87 Performance

Vitamin D3 25 mcg (1000 IU) & K2 120 mcg

Natural Factors
<p>Moderate vitamin D3 and MK-7 create a balanced maintenance pairing in a softgel, with only minor ambiguity from duplicate K2 source entries. Vitamin D intake from other sources still matters, especially for the higher-dose options. Vitamin K requires clinician-directed consistency with warfarin-type medicines.</p>
84 Performance

D3 + K2

Nature Made
<p>All-trans MK-7 and vitamin D3 use clearly defined forms in a focused softgel, improving active-form clarity. Vitamin D intake from other sources still matters, especially for the higher-dose options. Vitamin K requires clinician-directed consistency with warfarin-type medicines.</p>
88 Budget

Vitamin K2 MK-7 100 mcg

Nutricost
<p>At a lower serving cost, a clearly stated MK-7 amount creates a simple, easy-to-assess vitamin K2 option, although the dry capsule has no stated lipid carrier. It omits the original vitamin D3, so total vitamin D needs separate consideration. Vitamin K can oppose warfarin-type anticoagulants.</p>
87 Budget

MK-7 Vitamin K-2 100 mcg

NOW
<p>At a lower serving cost, a meaningful long-acting MK-7 amount provides focused vitamin K2 support with a simple active formula. It omits the original vitamin D3, so total vitamin D needs separate consideration. Vitamin K can oppose warfarin-type anticoagulants.</p>
85 Budget

Vitamin K2 MenaQ7 100 mcg

AN Amazing Nutrition Amazing Formulas
<p>At a lower serving cost, natto-derived MenaQ7 provides a clearly identified long-acting vitamin K2 form in a focused formula. It omits the original vitamin D3, so total vitamin D needs separate consideration. Vitamin K can oppose warfarin-type anticoagulants.</p>
86 Value

Vitamin K2 100 mcg + Vitamin D3 125 mcg

Nutricost
<p>MK-7 and vitamin D3 provide a fully disclosed combination at very favorable serving value, but the vitamin D amount is concentrated. The combination remains close to the original purpose, while total vitamin D intake should guide selection. Vitamin K can reduce the effect of warfarin-type anticoagulants.</p>
86 Value

Vitamins D3 2500 IU (62.5 mcg) & K2 120 mcg

NaturesPlus
<p>MK-7 and a substantial vitamin D3 amount provide focused bone and cardiovascular support at a low serving cost, though the dry tablet lacks a lipid carrier. The combination remains close to the original purpose, while total vitamin D intake should guide selection. Vitamin K can reduce the effect of warfarin-type anticoagulants.</p>
86 Value

Natural Vitamin K2 MK-7 with MenaQ7 100 mcg

Doctor's Best
<p>Branded MenaQ7 provides a meaningful long-acting K2 amount with clear active disclosure and good serving value. The combination remains close to the original purpose, while total vitamin D intake should guide selection. Vitamin K can reduce the effect of warfarin-type anticoagulants.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP · Journal of the American Heart Association · 2021
    Cohort study53,372 participantsHeart Health Cardiovascular Support forVitamin K
  2. Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials.
    Vlasschaert C; Goss CJ; Pilkey NG; McKeown S; Holden RM · Nutrients · 2021
    Systematic review9 studies pooledHeart Health forVitamin K
  3. Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial.
    Witham MD; Lees JS; White M; Band M; Bell S; Chantler DJ; Ford I; Fulton RL; Kennedy G; Littleford RC; McCrea IV; McGlynn D; Panarelli M; Ralston MR; Rutherford E; Severn A; Thomson N; Traynor JP; Struthers AD; Wetherall K; Mark PB · Journal of the American Society of Nephrology : JASN · 2021
    Randomized trial159 participantsHeart Health forVitamin K
  4. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial244 participantsBone Health forVitamin K
  5. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S · Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2001
    Randomized trial92 participantsBone Health forVitamin K
  6. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
    Huang ZB; Wan SL; Lu YJ; Ning L; Liu C; Fan SW · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2015
    Meta-analysis6,759 participants19 studies pooledBone Health forVitamin K
  7. Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL.
    Chou SH; Booth SL; Cook NR; Kim E; Kotler G; Fu X; Buring JE; Manson JE; LeBoff MS · JBMR plus · 2026
    Randomized trial771 participantsBone Health forVitamin K
  8. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
    Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C · Thrombosis and haemostasis · 2016
    Randomized trial244 participantsCardiovascular Support Heart Health forVitamin K
  9. The relationship between vitamin K and peripheral arterial disease.
    Vissers LET; Dalmeijer GW; Boer JMA; Verschuren WMM; van der Schouw YT; Beulens JWJ · Atherosclerosis · 2017
    Cohort study36,629 participantsCardiovascular Support forVitamin K
  10. Interventions to Attenuate Cardiovascular Calcification Progression: A Systematic Review of Randomized Clinical Trials.
    Murali S; Smith ER; Tiong MK; Tan SJ; Toussaint ND · Journal of the American Heart Association · 2024
    Systematic review9,901 participants49 studies pooledCardiovascular Support forVitamin K
  11. Joint association of serum 25-hydroxyvitamin D concentration and body mass index on the acceleration of clinical biomarker-based biological aging.
    Pan Z; Zeng J; Chen Z; Chen S; Yang J; Li H; Wang S; Wang J; Li N; Gong Y; Liu M; Li C · The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Cohort study389,217 participantsAnti-Aging forVitamin D
  12. Serum 25-Hydroxyvitamin D Levels as an Aging Marker: Strong Associations With Age and All-Cause Mortality Independent From Telomere Length, Epigenetic Age Acceleration, and 8-Isoprostane Levels.
    Schöttker B; Hagen L; Zhang Y; Gào X; Holleczek B; Gao X; Brenner H · The journals of gerontology. Series A, Biological sciences and medical sciences · 2019
    Cohort study9,940 participantsAnti-Aging forVitamin D
  13. Sex-specific associations of serum 25-hydroxyvitamin D concentrations with incident sarcopenia in older adults: A 2-year follow-up study.
    Song S; Lim JY; Kim M; Won CW; Park HY · The journal of nutrition, health & aging · 2025
    Cohort study1,292 participantsAnti-Aging forVitamin D
  14. Vitamin D deficit is associated with accelerated brain aging in the general population.
    Terock J; Bonk S; Frenzel S; Wittfeld K; Garvert L; Hosten N; Nauck M; Völzke H; Van der Auwera S; Grabe HJ · Psychiatry research. Neuroimaging · 2022
    Cross-sectional study1,865 participantsAnti-Aging forVitamin D
  15. Vitamin D intake is associated with dementia risk in the Washington Heights-Inwood Columbia Aging Project (WHICAP).
    Zhao C; Tsapanou A; Manly J; Schupf N; Brickman AM; Gu Y · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Cohort study1,759 participantsAnti-Aging forVitamin D
  16. Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
    Shea MK; Barger K; Booth SL; Matuszek G; Cushman M; Benjamin EJ; Kritchevsky SB; Weiner DE · The American journal of clinical nutrition · 2020
    Meta-analysis3,891 participants3 studies pooledAnti-Aging General Health forVitamin K
  17. Topical Menaquinone‑7 (Vitamin K2, MK-7) as a Mitochondrial Bioenergetic Activator for Skin Anti-Aging: Mechanistic Evidence in Skin Cells and a Randomized Split-Face/Neck Study.
    Huang H; Wei R; Xu C; Liu C; Zhao S; Li Y; Wang M · ACS omega · 2026
    Randomized trial30 participantsAnti-Aging forVitamin K
  18. Vitamin K status and cognitive function in healthy older adults.
    Presse N; Belleville S; Gaudreau P; Greenwood CE; Kergoat MJ; Morais JA; Payette H; Shatenstein B; Ferland G · Neurobiology of aging · 2014
    Cross-sectional study320 participantsAnti-Aging forVitamin K
  19. High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.
    Machado-Fragua MD; Hoogendijk EO; Struijk EA; Rodriguez-Artalejo F; Lopez-Garcia E; Beulens JW; van Ballegooijen AJ · European journal of nutrition · 2021
    Cohort study644 participantsAnti-Aging forVitamin K
  20. Vitamin K Concentration and Cognitive Status in Elderly Patients on Anticoagulant Therapy: A Pilot Study.
    Alisi L; Cafolla C; Gentili A; Tartaglione S; Curini R; Cafolla A · Journal of aging research · 2022
    Cross-sectional study85 participantsAnti-Aging forVitamin K
  21. What is the impact of daily oral supplementation of vitamin D3 (cholecalciferol) plus calcium on the incidence of hip fracture in older people? A systematic review and meta-analysis.
    Manoj P; Derwin R; George S · International journal of older people nursing · 2023
    Meta-analysis12,620 participants7 studies pooledBone Health forCalcium
  22. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial.
    Storm D; Eslin R; Porter ES; Musgrave K; Vereault D; Patton C; Kessenich C; Mohan S; Chen T; Holick MF; Rosen CJ · The Journal of clinical endocrinology and metabolism · 1998
    Randomized trial60 participantsBone Health forCalcium
  23. The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women.
    Prince R; Devine A; Dick I; Criddle A; Kerr D; Kent N; Price R; Randell A · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 1995
    Randomized trial168 participantsBone Health forCalcium
  24. The efficacy of calcium supplementation alone in elderly Thai women over a 2-year period: a randomized controlled trial.
    Rajatanavin R; Chailurkit L; Saetung S; Thakkinstian A; Nimitphong H · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial404 participantsBone Health forCalcium
  25. Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial.
    Bonjour JP; Carrie AL; Ferrari S; Clavien H; Slosman D; Theintz G; Rizzoli R · The Journal of clinical investigation · 1997
    Randomized trial149 participantsBone Health forCalcium
  26. Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial.
    Moon RJ; D' Angelo S; Curtis EM; Ward KA; Crozier SR; Schoenmakers I; Javaid MK; Bishop NJ; Godfrey KM; Cooper C; Harvey NC; MAVIDOS Trial Group · The American journal of clinical nutrition · 2024
    Randomized trial454 participantsBone Health forVitamin D
  27. Vitamin D analogs and bone: preclinical and clinical studies with eldecalcitol.
    Matsumoto T; Takano T; Saito H; Takahashi F · BoneKEy reports · 2014
    Narrative reviewBone Health forVitamin D
  28. Efficacy of vitamin D fortified foods on bone mineral density and serum bone biomarkers: A systematic review and meta-analysis of interventional studies.
    Tangestani H; Djafarian K; Emamat H; Arabzadegan N; Shab-Bidar S · Critical reviews in food science and nutrition · 2020
    Meta-analysis1,786 participants20 studies pooledBone Health forVitamin D
  29. Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial.
    Tsujita M; Doi Y; Obi Y; Hamano T; Tomosugi T; Futamura K; Okada M; Hiramitsu T; Goto N; Isaka Y; Takeda A; Narumi S; Watarai Y · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Randomized trial193 participantsBone Health forVitamin D
  30. Vitamin D supplementation and bone health in post-menopausal women: a 24-month randomized controlled intervention with enhanced bioavailability formulations.
    Rasool N; Munir Y · European journal of clinical nutrition · 2026
    Randomized trial612 participantsBone Health forVitamin D
  31. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
    Cockayne S; Adamson J; Lanham-New S; Shearer MJ; Gilbody S; Torgerson DJ · Archives of internal medicine · 2006
    Meta-analysis13 studies pooledBone Health forVitamin K
  32. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
    Zhou M; Han S; Zhang W; Wu D · Journal of bone and mineral metabolism · 2022
    Meta-analysis6,853 participants9 studies pooledBone Health forVitamin K
  33. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
    Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y · Journal of bone and mineral metabolism · 2015
    Randomized trial48 participantsBone Health forVitamin K
  34. Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
    de Vries F; Bittner R; Maresz K; Machuron F; Gåserød O; Jeanne JF; Schurgers LJ · Nutrients · 2025
    Randomized trial165 participantsCardiovascular Support forVitamin K
  35. Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
    Schultz CJ; Dalgaard F; Bellinge JW; Murray K; Sim M; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Gislason GH; Tjønneland A; Overvad K; Hodgson JM; Bondonno NP · Arteriosclerosis, thrombosis, and vascular biology · 2024
    Cohort study55,545 participantsCardiovascular Support Heart Health forVitamin K
  36. Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
    Palmer CR; Bellinge JW; Dalgaard F; Sim M; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Croft KD; Gislason G; Tjønneland A; Overvad K; Schultz C; Lewis JR; Hodgson JM; Bondonno NP · European journal of epidemiology · 2021
    Cohort study56,048 participantsCardiovascular Support Heart Health forVitamin K
  37. Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients.
    Huang Y; Zhu X; Han L; Hu H · Scientific reports · 2025
    Cohort study7,857 participantsGeneral Health forVitamin K
  38. The Effect of Topical Vitamin K1 on the Treatment of Cetuximab-Induced Skin Rashes in Metastatic Colorectal Cancer Patients.
    Roayaei M; Rezaei M; Najafizade N · Advanced biomedical research · 2024
    Randomized trial49 participantsGeneral Health forVitamin K
  39. Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
    Sun Z; Zhu K; Liang G; Yan F; Chao S; Jia L; Niu Y · Experimental and therapeutic medicine · 2023
    Meta-analysis7 studies pooledGeneral Health forVitamin K
  40. Vitamin K1 intake is associated with lower risk for all-cause and cardiovascular disease mortality in community-dwelling older Australian women.
    Dupuy M; Radavelli-Bagatini S; Zhong L; Dalla Via J; Zhu K; Blekkenhorst LC; Bondonno NP; Linneberg A; Bellinge JW; Schultz C; Courtney W; Prince RL; Hodgson JM; Lewis JR; Sim M · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2024
    Cohort study1,436 participantsGeneral Health forVitamin K
  41. Vitamin D supplementation for cardiometabolic risk markers in pregnant women based on the gestational diabetes mellitus or obesity status : a randomized clinical trial.
    Yin WJ; Wang P; Ma SS; Tao RX; Hu HL; Jiang XM; Zhang Y; Tao FB; Zhu P · European journal of nutrition · 2024
    Randomized trial1,537 participantsHeart Health forVitamin D
  42. Paricalcitol and endothelial function in chronic kidney disease trial.
    Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F · Hypertension (Dallas, Tex. : 1979) · 2015
    Randomized trial88 participantsHeart Health forVitamin D
  43. Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.
    Mirhosseini N; Rainsbury J; Kimball SM · Frontiers in cardiovascular medicine · 2020
    Meta-analysis81 studies pooledHeart Health forVitamin D
  44. Does vitamin D supplementation modulate metabolic risk factors of cardiovascular disease? A systematic review and meta-analysis of clinical trials.
    Abumweis S; Alqadi S; Al Tarteer A; Alrefai W; Alzoughool F; Jew S; Qudah T · Asia Pacific journal of clinical nutrition · 2026
    Meta-analysis45 studies pooledHeart Health forVitamin D
  45. Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
    Norouzzadeh M; Rashedi MH; Mahdavi-Mazdeh G; Kosari A; Shahinfar H · Current atherosclerosis reports · 2026
    Meta-analysisHeart Health forVitamin D
  46. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
    Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ · The American journal of clinical nutrition · 2022
    Randomized trial149 participantsHeart Health forVitamin K